COLD & ALLERGY RELIEF - LIQ 4 MG / 5 ML
BROMPHENIRAMINE MALEATE : 4 MG / 5 ML PHENYLEPHRINE HYDROCHLORIDE : 5 MG / 5 ML PHENYLPROPANOLAMINE HYDROCHLORIDE : 5 MG / 5 ML · DIN 02198916 · STANLEY PHARMACEUTICALS, A DIVISION OF VITA HEALTH PRODUCTS INC.
Health Canada status: CANCELLED POST MARKET
What is COLD & ALLERGY RELIEF - LIQ?
COLD & ALLERGY RELIEF - LIQ 4 MG / 5 ML contains BROMPHENIRAMINE MALEATE : 4 MG / 5 ML PHENYLEPHRINE HYDROCHLORIDE : 5 MG / 5 ML PHENYLPROPANOLAMINE HYDROCHLORIDE : 5 MG / 5 ML. It is listed in the Health Canada Drug Product Database under DIN 02198916, held by STANLEY PHARMACEUTICALS, A DIVISION OF VITA HEALTH PRODUCTS INC., supplied as LIQUID for ORAL administration. Health Canada currently lists it as cancelled post market, status dated 09-Apr-2001. Nexara Health is a licensed Canadian wholesale distributor (DEL 3-002896-A) and can source this product for hospitals, pharmacies and clinics. Availability and lead time are confirmed per order.
Product details and regulatory record
| DIN | 02198916 |
|---|---|
| Brand name | COLD & ALLERGY RELIEF - LIQ |
| Generic / active ingredient | BROMPHENIRAMINE MALEATE : 4 MG / 5 ML PHENYLEPHRINE HYDROCHLORIDE : 5 MG / 5 ML PHENYLPROPANOLAMINE HYDROCHLORIDE : 5 MG / 5 ML |
| Manufacturer | STANLEY PHARMACEUTICALS, A DIVISION OF VITA HEALTH PRODUCTS INC. |
| Strength | 4 MG / 5 ML |
| Dosage form | LIQUID |
| Route of administration | ORAL |
| Schedule | NON-PRESCRIPTION DRUGS |
| ATC code | R01BA51 PHENYLPROPANOLAMINE, COMBINATIONS |
| AHFS class | 12:12.00 ; 04:04.20 |
| Biosimilar | No |
| Health Canada status | CANCELLED POST MARKET |
| Status date | 09-Apr-2001 |
| Original market date | 1996-12-31 00:00:00 |
What can be used instead?
Other Canadian products sharing ATC code R01BA51 PHENYLPROPANOLAMINE, COMBINATIONS. 0 of 28 DINs in this group are currently marketed — marketed products are listed first, because that is what can actually be bought. These tables describe supply, not clinical equivalence: substitution rests with the prescriber or pharmacist, and interchangeability is determined provincially.
| Product | Strength | Form | Manufacturer | Health Canada status | DIN |
|---|---|---|---|---|---|
| BRONCHODEX D CAP | 50 MG | CAPSULE (SUSTAINED-RELEASE) | PRODEMDIS ENR. | CANCELLED POST MARKET | DIN 00547603 |
| CHLOR TRIPOLON DECONGEST SYR | 2.5 MG | SYRUP | SCHERING-PLOUGH CANADA INC | CANCELLED POST MARKET | DIN 00510882 |
| COLD DECONGESTANT LONG ACTING CAP | 50 MG | CAPSULE (SUSTAINED-RELEASE) | NOVOPHARM LIMITED | CANCELLED POST MARKET | DIN 00328286 |
| COLD RELIEF | 2 MG / 5 ML | LIQUID | PERRIGO INTERNATIONAL | CANCELLED POST MARKET | DIN 02231802 |
| CONTAC COLD CAPSULES | 8 MG | CAPSULE (SUSTAINED-RELEASE) | SMITHKLINE BEECHAM CONSUMER HEALTHCARE, DIVISION OF SMITHKLINE BEECHAM INC. | CANCELLED POST MARKET | DIN 02230326 |
| CONTAC COLD EXTRA STRENGTH CAPSULES | 75 MG | CAPSULE (SUSTAINED-RELEASE) | SMITHKLINE BEECHAM CONSUMER HEALTHCARE, DIVISION OF SMITHKLINE BEECHAM INC. | CANCELLED POST MARKET | DIN 02230425 |
| CONTACT C SRC | 75 MG | CAPSULE (SUSTAINED-RELEASE) | SMITHKLINE BEECHAM CONSUMER HEALTHCARE, DIVISION OF SMITHKLINE BEECHAM INC. | CANCELLED POST MARKET | DIN 01910469 |
| CORICIDIN D LONG ACTING TAB | 8 MG | TABLET (EXTENDED-RELEASE) | SCHERING-PLOUGH CANADA INC | CANCELLED POST MARKET | DIN 00723819 |
| CORSYM SUSPENSION | 4 MG / 5 ML | SUSPENSION | CIBA SELF MEDICATION | CANCELLED POST MARKET | DIN 02018411 |
| DECONGESTANT ANTIHISTAMINIC SYRUP | 5 MG / 5 ML | ELIXIR | PHARMASCIENCE INC | CANCELLED POST MARKET | DIN 00576689 |
Can this still be bought in Canada?
No. This Drug Identification Number is cancelled post market in Health Canada's Drug Product Database, so the product is no longer authorized for sale in Canada and Nexara does not supply it. This page is kept as a regulatory record.
If you are looking for a current equivalent, the alternatives above list every product sharing this therapeutic class, with the marketed ones first. Ask us to source an alternative
Ordering questions
Who can buy this from Nexara?
Licensed entities only. Nexara holds Health Canada establishment licence DEL 3-002896-A and ships only to a licensed address.
Is there a minimum order?
Yes, set per product line and per pack multiple rather than on the order total, so you are never asked to buy a part-pack. The minimum for this line is confirmed with your quote.
What is the lead time?
Confirmed per order at quotation, and it depends on current stock position and whether the product is in shortage.
Can Nexara supply this for a clinical trial?
Yes — comparator and background-therapy supply, including sourcing from other markets where a Canadian pack will not satisfy the protocol. Clinical trial supply.